Jackson Square Partners, LLC Dexcom Inc Transaction History

Jackson Square Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$67.99 - $132.89 $10.7 Million - $20.9 Million	-157,121 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$94.08 - $130.2 $43,182 - $59,761	459 Added 0.29%	157,121 $80.4 Million
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $1.06 Million - $1.33 Million	-8,194 Reduced 4.97%	156,662 $84.1 Million
Q3 2021 Nov 12, 2021	SELL	$106.71 - $143.18 $39,589 - $53,119	-371 Reduced 0.22%	164,856 $90.2 Million
Q2 2021 Aug 13, 2021	SELL	$80.99 - $107.93 $3.54 Million - $4.71 Million	-43,655 Reduced 20.9%	165,227 $70.6 Million
Q1 2021 May 13, 2021	SELL	$84.79 - $104.74 $446,504 - $551,560	-5,266 Reduced 2.46%	208,882 $75.1 Million
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $21,450 - $28,737	-275 Reduced 0.13%	214,148 $79.2 Million
Q3 2020 Nov 13, 2020	BUY	$95.51 - $112.95 $9.19 Million - $10.9 Million	96,175 Added 81.33%	214,423 $88.4 Million
Q2 2020 Aug 07, 2020	BUY	$62.68 - $105.34 $7.41 Million - $12.5 Million	118,248 New	118,248 $47.9 Million

1,013

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Jackson Square Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Square Partners, LLC with notifications on news.